177Lu-DOTATATE Modified Delivery Based on Individualized Dosimetry

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
177Lu-DOTATATE Modified Delivery Based on Individualized Dosimetry	Neoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, Neoplasms, Nerve Tissue, neoplasm, neuroendocrine neoplasm, primitive neuroectodermal tumor	Recruiting	Phase 2	2025-07-22		NCT06395402

2 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Novartis	114
University of Iowa	102

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Holden Comprehensive Cancer Center at the University of Iowa	Iowa City	United States	2

Clinical trials